US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Gelteq

0.8061

+0.00610.76%

Post-market: 0.80610.00000.00%17:29 EST

Volume:11.49K

Turnover:9.32K

Market Cap:8.63M

PE:-1.71

High:0.8830

Open:0.7890

Low:0.7890

Close:0.8000

52wk High:4.11

52wk Low:0.6700

Shares:10.71M

Float Shares:4.77M

Volume Ratio:0.37

T/O Rate:0.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4720

EPS(LYR):-0.4699

ROE:-42.99%

ROA:-15.00%

PB:0.78

PE(LYR):-1.72

Loading ...

Overview Company News Filings

Bank of America, Citigroup And 3 Stocks To Watch Heading Into Wednesday

What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?

Benzinga_recent_news

Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform

Gelteq announces preclinical results on medicinal cannabinoid absorption

Gelteq Oral Gel Boosts Medicinal Cannabinoid Absorption in Preclinical Study

Gelteq Secures $1.3 Million Sales Agreement With Shenzhen Mana Health Management

Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program

Gelteq Signs Three-Year Sales Agreement With Shenzhen Mana Health Management for Nutritional Products in China

Gelteq Signs Three Year Sales Agreement With Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion Into China

THOMSON REUTERS

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

Gelteq to Present at Investor Summit Virtual on December 9, 2025

Gelteq announces ‘positive’ preclinical results for its gel formulation

Gelteq Ltd - Formulation Shows 38-45% Increase in Systemic Exposure

THOMSON REUTERS

Gelteq Ltd: Anticipates Using These Results to Further Pursue FDA Approval Pathway for Antihistamine Product

THOMSON REUTERS

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

Gelteq Ltd. Delays Financial Report Filing

Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform

Gelteq enters Product Development, Profit Share Agreement with Melbourne Health

Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound

Gelteq powers U.S. product launches of Healthy Extracts

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GELS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GELS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GELS\",,,,,undefined,":{"symbol":"GELS","market":"US","secType":"STK","nameCN":"Gelteq","latestPrice":0.8061,"timestamp":1770411600000,"preClose":0.8,"halted":0,"volume":11486,"hourTrading":{"tag":"盘后","latestPrice":0.8061,"preClose":0.8061,"latestTime":"17:29 EST","volume":120,"amount":96.732,"timestamp":1770416978898,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007624999999999993,"floatShares":4772600,"shares":10711059,"eps":-0.472038,"marketStatus":"Market Closed","change":0.0061,"latestTime":"02-06 16:00:00 EST","open":0.789,"high":0.883,"low":0.789,"amount":9322.0697608,"amplitude":0.1175,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.472038,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1710129600000,"exchange":"NASDAQ","adjPreClose":0.8,"preHourTrading":{"tag":"盘前","latestPrice":0.8,"preClose":0.8,"latestTime":"08:50 EST","volume":10,"amount":8,"timestamp":1770385847153,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.8061,"preClose":0.8061,"latestTime":"17:29 EST","volume":120,"amount":96.732,"timestamp":1770416978898,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.36922},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GELS\",,,,,undefined,":{"symbol":"GELS","floatShares":4772600,"roa":"-15.00%","roe":"-42.99%","lyrEps":-0.46987,"volumeRatio":0.36922,"shares":10711059,"dividePrice":0,"high":0.883,"amplitude":0.1175,"preClose":0.8,"low":0.789,"week52Low":0.67,"pbRate":"0.78","psRate":"29.80","week52High":4.11,"institutionHeld":0,"latestPrice":0.8061,"eps":-0.472038,"divideRate":0,"volume":11486,"delay":0,"ttmEps":-0.472038,"open":0.789,"prevYearClose":0.8,"prevWeekClose":0.9701,"prevMonthClose":0.9701,"prevQuarterClose":0.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GELS\",params:#limit:5,,,undefined,":[{"date":"2025-11-17","symbol":"GELS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763370000000,"name":null,"time":"Pre-Market","dateTimestamp":1763355600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GELS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GELS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GELS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GELS","date":"2026-02-05","current":-1.707701,"percent":0.978056,"low":-21.180883,"twenty":-9.211458,"median":-5.03732,"eighty":-3.200122,"high":-1.889922,"avg":-6.066017,"sd":3.525463,"marketCap":9219008},"quantilePoints":[{"date":"2024-10-24","current":-21.171054,"twenty":-21.176952,"median":-21.171054,"eighty":-21.074172,"marketCap":47190375},{"date":"2024-10-31","current":-10.143847,"twenty":-21.171054,"median":-19.0715,"eighty":-12.552606,"marketCap":22364462},{"date":"2024-11-08","current":-9.685721,"twenty":-21.009583,"median":-10.835689,"eighty":-10.558646,"marketCap":21707572},{"date":"2024-11-15","current":-7.014552,"twenty":-17.133417,"median":-10.60161,"eighty":-9.685721,"marketCap":15289681},{"date":"2024-11-22","current":-6.416922,"twenty":-12.552606,"median":-9.926334,"eighty":-6.79528,"marketCap":14817777},{"date":"2024-11-29","current":-8.190394,"twenty":-11.179072,"median":-9.685721,"eighty":-6.866778,"marketCap":18876150},{"date":"2024-12-06","current":-7.936263,"twenty":-11.904907,"median":-9.791242,"eighty":-6.988572,"marketCap":18122047},{"date":"2024-12-13","current":-12.717639,"twenty":-15.037311,"median":-9.919814,"eighty":-7.370907,"marketCap":28786128},{"date":"2024-12-20","current":-11.5646,"twenty":-14.084739,"median":-10.03509,"eighty":-7.492432,"marketCap":25671564},{"date":"2024-12-27","current":-10.521358,"twenty":-13.396579,"median":-10.430145,"eighty":-7.577881,"marketCap":23217664},{"date":"2025-01-03","current":-10.212771,"twenty":-12.928337,"median":-10.31691,"eighty":-7.75217,"marketCap":22462618},{"date":"2025-01-10","current":-10.447375,"twenty":-12.684632,"median":-10.31691,"eighty":-7.987089,"marketCap":22934522},{"date":"2025-01-17","current":-9.200073,"twenty":-12.390681,"median":-10.143847,"eighty":-8.199443,"marketCap":20291861},{"date":"2025-01-24","current":-12.250467,"twenty":-12.250467,"median":-10.143847,"eighty":-8.235639,"marketCap":27276036},{"date":"2025-01-31","current":-10.587756,"twenty":-11.945486,"median":-10.357767,"eighty":-8.242559,"marketCap":23406426},{"date":"2025-02-07","current":-9.613276,"twenty":-11.838374,"median":-10.143847,"eighty":-8.385479,"marketCap":21424430},{"date":"2025-02-14","current":-9.335065,"twenty":-11.742982,"median":-9.930432,"eighty":-8.685186,"marketCap":20858145},{"date":"2025-02-21","current":-7.993593,"twenty":-11.740961,"median":-9.908289,"eighty":-8.625245,"marketCap":18121104},{"date":"2025-02-28","current":-7.747281,"twenty":-11.599771,"median":-9.805823,"eighty":-8.159414,"marketCap":17177296},{"date":"2025-03-07","current":-5.562716,"twenty":-11.549627,"median":-9.695809,"eighty":-7.723713,"marketCap":12552639},{"date":"2025-03-14","current":-5.584478,"twenty":-11.472534,"median":-9.668507,"eighty":-7.362691,"marketCap":12458259},{"date":"2025-03-21","current":-4.149201,"twenty":-11.277341,"median":-9.487625,"eighty":-6.968767,"marketCap":9261582},{"date":"2025-03-28","current":-4.577543,"twenty":-11.093076,"median":-9.44388,"eighty":-6.473516,"marketCap":10242198},{"date":"2025-04-04","current":-3.851321,"twenty":-10.880164,"median":-9.282379,"eighty":-6.008181,"marketCap":8683029},{"date":"2025-04-11","current":-3.89689,"twenty":-10.716997,"median":-9.200073,"eighty":-5.580126,"marketCap":8588648},{"date":"2025-04-17","current":-3.646379,"twenty":-10.661675,"median":-8.819833,"eighty":-5.383561,"marketCap":8249821},{"date":"2025-04-25","current":-9.652752,"twenty":-10.74667,"median":-8.869441,"eighty":-5.247315,"marketCap":21896334},{"date":"2025-05-02","current":-7.750229,"twenty":-10.661675,"median":-8.814953,"eighty":-5.383561,"marketCap":17554819},{"date":"2025-05-09","current":-6.139277,"twenty":-10.630285,"median":-8.735518,"eighty":-5.474378,"marketCap":13968351},{"date":"2025-05-16","current":-6.99216,"twenty":-10.600957,"median":-8.610931,"eighty":-5.545986,"marketCap":15855966},{"date":"2025-05-23","current":-7.675573,"twenty":-10.57029,"median":-8.239099,"eighty":-5.575773,"marketCap":17460438},{"date":"2025-05-30","current":-6.938057,"twenty":-10.543731,"median":-8.112944,"eighty":-5.636827,"marketCap":15855966},{"date":"2025-06-06","current":-6.975935,"twenty":-10.504597,"median":-7.936263,"eighty":-5.717132,"marketCap":16139108},{"date":"2025-06-13","current":-9.387733,"twenty":-10.504597,"median":-7.964928,"eighty":-5.73826,"marketCap":21707572},{"date":"2025-06-20","current":-7.464332,"twenty":-10.47304,"median":-7.909895,"eighty":-5.7777,"marketCap":17082915},{"date":"2025-06-27","current":-7.644932,"twenty":-10.445748,"median":-7.818055,"eighty":-5.845868,"marketCap":17743581},{"date":"2025-07-03","current":-4.783069,"twenty":-10.439239,"median":-7.807589,"eighty":-5.765943,"marketCap":16233489},{"date":"2025-07-11","current":-5.323861,"twenty":-10.42105,"median":-7.711427,"eighty":-5.562716,"marketCap":18047560},{"date":"2025-07-18","current":-5.389902,"twenty":-10.294483,"median":-7.629441,"eighty":-5.389902,"marketCap":18047560},{"date":"2025-07-25","current":-5.289267,"twenty":-10.212771,"median":-7.530155,"eighty":-5.323861,"marketCap":18047560},{"date":"2025-08-01","current":-5.027113,"twenty":-10.143847,"median":-7.464332,"eighty":-5.289267,"marketCap":16696406},{"date":"2025-08-08","current":-4.542521,"twenty":-9.955308,"median":-7.44921,"eighty":-5.176129,"marketCap":15248741},{"date":"2025-08-15","current":-4.086764,"twenty":-9.934529,"median":-7.347754,"eighty":-5.027113,"marketCap":13704564},{"date":"2025-08-22","current":-3.666074,"twenty":-9.926334,"median":-7.208578,"eighty":-4.89559,"marketCap":12160388},{"date":"2025-08-29","current":-3.7227,"twenty":-9.919814,"median":-7.014552,"eighty":-4.783069,"marketCap":12546432},{"date":"2025-09-05","current":-2.756963,"twenty":-9.901373,"median":-6.99216,"eighty":-4.681949,"marketCap":9265057},{"date":"2025-09-12","current":-4.212457,"twenty":-9.86637,"median":-6.956996,"eighty":-4.570539,"marketCap":14476653},{"date":"2025-09-19","current":-4.123314,"twenty":-9.816413,"median":-6.93514,"eighty":-4.479423,"marketCap":14090608},{"date":"2025-09-26","current":-3.853267,"twenty":-9.744119,"median":-6.895327,"eighty":-4.409409,"marketCap":13028987},{"date":"2025-10-03","current":-3.518907,"twenty":-9.710456,"median":-6.851423,"eighty":-4.336967,"marketCap":11967366},{"date":"2025-10-10","current":-3.878506,"twenty":-9.705099,"median":-6.604267,"eighty":-4.157804,"marketCap":13125498},{"date":"2025-10-17","current":-3.680017,"twenty":-9.689557,"median":-6.556148,"eighty":-4.086764,"marketCap":12353410},{"date":"2025-10-24","current":-3.989256,"twenty":-9.679773,"median":-6.417549,"eighty":-3.986894,"marketCap":13415031},{"date":"2025-10-31","current":-3.336,"twenty":-9.670463,"median":-6.193795,"eighty":-3.910376,"marketCap":11291789},{"date":"2025-11-07","current":-3.092859,"twenty":-9.655903,"median":-6.107898,"eighty":-3.896214,"marketCap":10326679},{"date":"2025-11-14","current":-2.879417,"twenty":-9.621171,"median":-5.948315,"eighty":-3.877357,"marketCap":9747613},{"date":"2025-11-21","current":-1.989951,"twenty":-9.563454,"median":-5.877577,"eighty":-3.852878,"marketCap":8553771},{"date":"2025-11-28","current":-2.664711,"twenty":-9.516787,"median":-5.742874,"eighty":-3.830455,"marketCap":11567943},{"date":"2025-12-05","current":-2.678242,"twenty":-9.486354,"median":-5.584478,"eighty":-3.774196,"marketCap":11782164},{"date":"2025-12-12","current":-2.635623,"twenty":-9.470436,"median":-5.526781,"eighty":-3.720265,"marketCap":11675054},{"date":"2025-12-19","current":-2.092824,"twenty":-9.451613,"median":-5.438383,"eighty":-3.680017,"marketCap":9210439},{"date":"2025-12-26","current":-2.092725,"twenty":-9.421421,"median":-5.404609,"eighty":-3.654535,"marketCap":9318621},{"date":"2026-01-02","current":-1.932469,"twenty":-9.377199,"median":-5.375813,"eighty":-3.628391,"marketCap":8568847},{"date":"2026-01-09","current":-2.081774,"twenty":-9.328311,"median":-5.337925,"eighty":-3.551574,"marketCap":9254354},{"date":"2026-01-16","current":-2.978739,"twenty":-9.293728,"median":-5.253752,"eighty":-3.518165,"marketCap":13281713},{"date":"2026-01-23","current":-2.759102,"twenty":-9.263464,"median":-5.203618,"eighty":-3.433545,"marketCap":12531939},{"date":"2026-01-30","current":-2.326439,"twenty":-9.256997,"median":-5.123533,"eighty":-3.336,"marketCap":10818169},{"date":"2026-02-05","current":-1.991698,"twenty":-9.211458,"median":-5.03732,"eighty":-3.200122,"marketCap":9219008}],"updateTime":1770423587277},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GELS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603469663","title":"Bank of America, Citigroup And 3 Stocks To Watch Heading Into Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2603469663","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603469663?lang=en_us&edition=fundamental","pubTime":"2026-01-14 16:57","pubTimestamp":1768381056,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/26/01/49897931/bank-of-america-citigroup-and-3-stocks-to-watch-heading-into-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251131958.USD","IE0002270589.USD","LU0130102774.USD","LU2125154935.USD","BK4566","LU0162691827.USD","LU2360032135.SGD","BK4581","LU0648000940.SGD","LU1894683348.USD","C","LU2461242641.AUD","LU0203345920.USD","LU0175139822.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0251142724.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU1506573853.SGD","BK4504","LU2133065610.SGD","BK4534","IE0001KFT4U8.USD","LU0320765646.SGD","LU0306807586.USD","BAC","LU0154236417.USD","BK4139","LU1804176565.USD","TGTX","LU1668664300.SGD","BK4501","LU1496350171.SGD","LU0098860793.USD","LU1280957306.USD","LU1244550577.SGD","LU0256863902.USD","IE00BBT3K403.USD","LU0208291251.USD","IE000M9KFDE8.USD","LU0477156953.USD","IE00BKVL7J92.USD","LU0234572021.USD","GELS","BK4588","IE00BSNM7G36.USD","LU1267930227.SGD","LU0130103400.USD","LU0321505868.SGD"],"gpt_icon":0},{"id":"2603366655","title":"What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603366655","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603366655?lang=en_us&edition=fundamental","pubTime":"2026-01-14 12:01","pubTimestamp":1768363260,"startTime":"0","endTime":"0","summary":"Shares of Gelteq Ltd. jumped 69.25% in after-hours trading following the company's announcement of encouraging preclinical data for its cannabinoid oral gel platform.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/13/Stock-Market-Or-Forex-Trading-Graph-In-F.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/13/Stock-Market-Or-Forex-Trading-Graph-In-F.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/01/49896114/whats-driving-gelteq-ltd-s-gels-over-69-after-hours-surge","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/01/49896114/whats-driving-gelteq-ltd-s-gels-over-69-after-hours-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["RSI","BK4007","BK4150","GELS"],"gpt_icon":0},{"id":"2603490680","title":"Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2603490680","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603490680?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:21","pubTimestamp":1768314078,"startTime":"0","endTime":"0","summary":"Jan 13 (Reuters) - Gelteq Ltd ::*GELTEQ ANNOUNCES POSITIVE PRECLINICAL RESULTS SHOWING INCREASED MEDICINAL CANNABINOID ABSORPTION USING ITS ORAL GEL DELIVERY PLATFORM  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-JAN-202614:00:01.437 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nRSD39dMPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2603680954","title":"Gelteq announces preclinical results on medicinal cannabinoid absorption","url":"https://stock-news.laohu8.com/highlight/detail?id=2603680954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603680954?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:16","pubTimestamp":1768313780,"startTime":"0","endTime":"0","summary":"Gelteq (GELS) announced positive results from a recently completed preclinical study which evaluated medicinal cannabinoids delivery through the Co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gelteq-announces-preclinical-results-on-medicinal-cannabinoid-absorption-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gelteq-announces-preclinical-results-on-medicinal-cannabinoid-absorption-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2603687462","title":"Gelteq Oral Gel Boosts Medicinal Cannabinoid Absorption in Preclinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2603687462","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603687462?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:01","pubTimestamp":1768312893,"startTime":"0","endTime":"0","summary":"Gelteq Ltd. has announced positive results from a recently completed preclinical study evaluating the delivery of medicinal cannabinoids using its proprietary oral gel platform. The study demonstrated that the oral gel significantly enhances the absorption and bioavailability of cannabidiol  compared to an existing FDA-approved oil-based product. The results have already been presented. According to the company, this advancement could support accelerated partnerships and product launches, including licensing and co-development opportunities with medicinal cannabis companies, and may facilitate faster market entry through the Australian government's SAS program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gelteq Ltd. published the or","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL3ZGD6H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4585","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","BK4588","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4007","IE00B3QW5Z07.USD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","SG9999014021.USD","GELS"],"gpt_icon":0},{"id":"2591803379","title":"Gelteq Secures $1.3 Million Sales Agreement With Shenzhen Mana Health Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2591803379","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591803379?lang=en_us&edition=fundamental","pubTime":"2025-12-16 22:05","pubTimestamp":1765893916,"startTime":"0","endTime":"0","summary":"Gelteq Ltd., a company specializing in gel-based oral delivery solutions, has announced a new partnership with the Hong Kong Flag Football Program. As part of this collaboration, Gelteq's hydration and sports performance gel formulations will be integrated into the training and competition programs of Hong Kong's men's, women's, and youth national flag football teams. The announcement also references a previously disclosed sales agreement with Shenzhen Mana Health Management Co. Ltd. in China, which includes minimum annual order commitments totaling at least USD $1.3 million over the term of the agreement. These developments reflect the growing commercial adoption of Gelteq's technology in sports and wellness applications across Southeast Asia.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL8cy8ZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","SG9999014021.USD","BK4007","IE00BGHQF748.EUR","NDAQ","GELS","SG9999014039.USD","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014013.SGD","BK4588","LU2210149790.SGD"],"gpt_icon":0},{"id":"2591803409","title":"Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2591803409","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591803409?lang=en_us&edition=fundamental","pubTime":"2025-12-16 22:05","pubTimestamp":1765893900,"startTime":"0","endTime":"0","summary":"Collaboration Combines Growing International Interest in Gelteq’s Sports Science Technology with Rising Interest in Flag Football Ahead of 2028 Summer Olympic Games Debut in Los AngelesMELBOURNE, Aust","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206326/0/en/Gelteq-Furthers-Asia-Presence-Through-Partnership-with-Hong-Kong-Flag-Football-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2590344247","title":"Gelteq Signs Three-Year Sales Agreement With Shenzhen Mana Health Management for Nutritional Products in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2590344247","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590344247?lang=en_us&edition=fundamental","pubTime":"2025-12-09 22:15","pubTimestamp":1765289721,"startTime":"0","endTime":"0","summary":"Gelteq Ltd., an innovator in gel-based oral delivery technologies, has announced the signing of a three-year sales agreement with Shenzhen Mana Health Management Co. Ltd. Under the agreement, Mana will distribute Gelteq's proprietary nutritional gel formulations in China, primarily focusing on a product aimed at sugar lowering. The contract includes minimum annual order volumes, with Gelteq expecting to generate at least USD $1.3 million in revenue over the term of the agreement. Mana will utilize its digital and offline retail channels to promote, market, and sell Gelteq's products across China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gelteq Ltd. published the original content used to generate this news brief via GlobeNewswire ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL2Y7gKV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014013.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","GELS","IE00BKPKM429.USD","NDAQ","LU0314104364.USD","SG9999014039.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014005.SGD","BK4585","BK4007","BK4112"],"gpt_icon":0},{"id":"2590124344","title":"Gelteq Signs Three Year Sales Agreement With Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion Into China","url":"https://stock-news.laohu8.com/highlight/detail?id=2590124344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590124344?lang=en_us&edition=fundamental","pubTime":"2025-12-09 22:15","pubTimestamp":1765289700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUA1CRGZ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2589816832","title":"Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2589816832","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589816832?lang=en_us&edition=fundamental","pubTime":"2025-12-05 23:30","pubTimestamp":1764948600,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Dec.  05, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announce","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/05/3200842/0/en/Gelteq-Preclinical-Study-Demonstrates-Enhanced-Oral-Delivery-of-Oil-Soluble-and-Poorly-Soluble-Drugs-Using-Its-Gel-Based-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4535","API","BK4023","GELS","BK4551","BK4503"],"gpt_icon":0},{"id":"2588055228","title":"Gelteq to Present at Investor Summit Virtual on December 9, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588055228","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588055228?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:30","pubTimestamp":1764682200,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Dec.  02, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (Nasdaq: GELS) (“Gelteq”) today announced that Nathan Givoni, its Chief Executive Officer, will present at theQ4 Investor Summi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197958/0/en/Gelteq-to-Present-at-Investor-Summit-Virtual-on-December-9-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HNW","SMMF","BK4211","BK4007","GELS"],"gpt_icon":0},{"id":"2585007467","title":"Gelteq announces ‘positive’ preclinical results for its gel formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2585007467","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585007467?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:45","pubTimestamp":1763991952,"startTime":"0","endTime":"0","summary":"The company states: “Gelteq (GELS) Limited announced positive preclinical results showing its proprietary gel formulation achieved substantially hi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gelteq-announces-positive-preclinical-results-for-its-gel-formulation-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gelteq-announces-positive-preclinical-results-for-its-gel-formulation-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2585467508","title":"Gelteq Ltd - Formulation Shows 38-45% Increase in Systemic Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2585467508","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585467508?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:31","pubTimestamp":1763991060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X00EF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2585446752","title":"Gelteq Ltd: Anticipates Using These Results to Further Pursue FDA Approval Pathway for Antihistamine Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2585446752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585446752?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:31","pubTimestamp":1763991060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X00EF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2585946765","title":"Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2585946765","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585946765?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:30","pubTimestamp":1763991000,"startTime":"0","endTime":"0","summary":"Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug ClassesMELBOURNE, Australia, Nov.  24, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”),","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193490/0/en/Gelteq-Announces-Positive-Preclinical-Results-Demonstrating-Enhanced-Bioavailability-Using-Its-Proprietary-Gel-Based-Drug-Delivery-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS"],"gpt_icon":0},{"id":"2580797226","title":"Gelteq Ltd. Delays Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2580797226","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580797226?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:01","pubTimestamp":1762207288,"startTime":"0","endTime":"0","summary":"Gelteq Limited has disclosed a delay in filing its required financial report. The company stated that the report could not be filed within the prescribed time period without unreasonable effort or expense but expects to file it within the allowed extension period. The specific financial period and form type were not provided in the document.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gelteq Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDLbLnqQm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2577079093","title":"Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2577079093","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577079093?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:00","pubTimestamp":1761224400,"startTime":"0","endTime":"0","summary":"Collaboration with Monash University to Address a Large Pharmaceutical OpportunityMELBOURNE, Australia, Oct.  23, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/23/3172100/0/en/Gelteq-Announces-Commencement-of-Preclinical-Trial-Targeting-Oil-Soluble-Drug-Market-with-Novel-Delivery-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2574529141","title":"Gelteq enters Product Development, Profit Share Agreement with Melbourne Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2574529141","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574529141?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:21","pubTimestamp":1760012461,"startTime":"0","endTime":"0","summary":"Gelteq (GELS) announced it has entered into a Product Development and Profit Share Agreement, with Melbourne Health, operator of The Royal Melbourn...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gelteq-enters-product-development-profit-share-agreement-with-melbourne-health-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gelteq-enters-product-development-profit-share-agreement-with-melbourne-health-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2574152998","title":"Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound","url":"https://stock-news.laohu8.com/highlight/detail?id=2574152998","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574152998?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:00","pubTimestamp":1760011200,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Oct.  09, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today anno","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/09/3164076/0/en/Gelteq-Announces-New-Product-Development-Agreement-with-Melbourne-Health-for-Novel-Bowel-Polyp-Growth-Reduction-Compound.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2566897618","title":"Gelteq powers U.S. product launches of Healthy Extracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2566897618","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566897618?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:35","pubTimestamp":1757676939,"startTime":"0","endTime":"0","summary":"Gelteq (GELS) announces recent product launches of Healthy Extracts, whose products apply Gelteq’s proprietary gel technology, into the U.S. nutrac...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gelteq-powers-u-s-product-launches-of-healthy-extracts-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gelteq-powers-u-s-product-launches-of-healthy-extracts-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GELS","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}